Hewlett-Packard/Genentech joint venture
Executive Summary
Hewlett-Packard acquires all of Genentech's 20% interest in the two companies' joint venture, HP Genenchem, for an undisclosed amount of cash, and royalties from products resulting from collaborative efforts. Since its creation in 1983, the joint venture has developed several products with bioscience applications, including automated systems for microassays and HPLC columns.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.